Expanding the Repertoire for “Large Small Molecules”: Prodrug ABBV-167 Efficiently Converts to Venetoclax with Reduced Food Effect in Healthy Volunteers-Reference-Cited by-同舟云学术

Expanding the Repertoire for “Large Small Molecules”: Prodrug ABBV-167 Efficiently Converts to Venetoclax with Reduced Food Effect in Healthy Volunteers

Published:2021-03-30 Issue:6 Volume:20 Page:999-1008
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Salem Ahmed Hamed^ORCID,Tao Zhi-Fu,Bueno Orlando F.,Chen Jie^ORCID,Chen Shuang,Edalji Rohinton,Elmore Steven W.,Fournier Keith M.,Harper Kaid C.,Hong Richard,Jenkins Gary J.,Ji Jianguo,Judge Russell A.^ORCID,Kalvass John C.,Klix Russell C.,Ku Yi-Yin^ORCID,Leverson Joel D.,Marks Richard A.,Marsh Kennan C.,Menon Rajeev M.,Park Chang H.,Phillips Darren C.,Pu Yu-Ming,Rosenberg Saul H.,Sanzgiri Yeshwant D.,Sheikh Ahmad Y.^ORCID,Shi Yi,Stolarik Deanne,Suleiman Ahmed A.,Wang Xilu,Zhang Geoff G.Z.,Catron Nathaniel D.,Souers Andrew J.

Funder

AbbVie

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3‐mimetics using virtual tumors calibrated with cell viability assays;CPT: Pharmacometrics & Systems Pharmacology;2024-05-15

2. Clinical pharmacokinetics and pharmacodynamics of venetoclax, a selective B‐cell lymphoma‐2 inhibitor;Clinical and Translational Science;2024-05

3. The landscape of small-molecule prodrugs;Nature Reviews Drug Discovery;2024-04-02

4. Phosphate Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs;Current Medicinal Chemistry;2024-01

5. Potential Hepatoprotective Effects of Chamaecyparis lawsoniana against Methotrexate-Induced Liver Injury: Integrated Phytochemical Profiling, Target Network Analysis, and Experimental Validation;Antioxidants;2023-12-14